Stock listing

Oxurion Nv

Selected listing: 0G99 · LSE · EUR · GB

Oxurion Nv (LSE:0G99), Health Technology. Latest release Sep 30, 2026: Oxurion : Interim Financial Report — Half-year results as of 30 June 2026 (EN).

0G99:LSEEURGBUpdated October 3, 2026

Ticker: LSE:0G99
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: LSE
Currency: EUR

Latest news from Oxurion Nv

Oxurion : Interim Financial Report — Half-year results as of 30 June 2026 (EN)

September 30, 2026

Oxurion Nv : Oxurion Publishes First Half 2026 Results

September 30, 2026

Oxurion Nv : Oxurion enters into exclusive negotiations to acquire the business and assets of Eclevar, a MedTech-focused CRO

September 30, 2026

Oxurion Nv : Oxurion expands its clinical research platform through strategic biometrics partnership between Axiodis CRO and KYomed INNOV

July 21, 2026

Oxurion Nv : Oxurion achieves another milestone in the expansion of the Exagis platform with the commercial launch of its eTMF module

July 6, 2026

All Oxurion Nv news →

Research Oxurion Nv

Oxurion Nv company profile

View the public company page for Oxurion Nv on 6ix.

Oxurion Nv news

Read company news and market updates connected to Oxurion Nv.

Oxurion Nv investor events

Find investor webinars, events, and replay context for Oxurion Nv.